RSS   Newsletter   Contact   Advertise with us
Post Online Media

Intrexon appoints Geno Germano as president

IntrexonIntrexon Corporation, a biotechnology company, announced the appointment of Geno Germano to the new role of president from June 1, 2016.
Mr. Germano brings to Intrexon over 30 years of experience in the pharmaceutical industry and a range of leadership roles in therapeutic categories and global markets at Pfizer, Wyeth and Johnson & Johnson.

Most recently he was Group President of Pfizer's Global Innovative Pharma Business. He was also Co-Chair of the Portfolio Strategy and Investment Committee.

Previously, Mr. Germano served as President and General Manager of Pfizer's Specialty Care and Oncology business.

Prior to joining Pfizer, he also held numerous executive and leadership roles at Wyeth Pharmaceuticals including President of Wyeth U.S. as well as President of its Global Pharmaceutical and Women's Healthcare Business.

Mr. Germano is a Trustee of the Albany College of Pharmacy where he received his Bachelor of Science degree in Pharmacy.




We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy